Single-stage Surgery Using the BHX Implant

2019-08-05 15:53:31 | BioPortfolio


Over the last few decades, the classical two-stage surgical procedure for inserting bone-anchored hearing implants (BAHIs) has been modified in adults into a single-stage procedure. This approach has several advantages since it avoids a second surgical procedure. The single-stage approach is proven to be safe and feasible in adults and is nowadays referred to as the standard surgical technique in adults. Despite favorable outcomes and advantages of the single-stage surgery, most Ear Nose Throat (ENT) surgeons still perform two-stage surgery when inserting BAHI in the pediatric population. Therefore, the aim of this study is to compare implant loss between single-stage BAHI surgery and two-stage BAHI surgery in children aged 4 to 9 years.


General description:

A prospective comparative study with historical control group will be performed.The test group will consist of 22 children aged 4-9 years old who are found to be suitable candidates for treatment with a BAHI (BHX implant and abutment). The control group consists of approximately 50 children, aged 4-9 years old, who already underwent insertion with a wide diameter implant between 2012 and 2018. In the test group, BAHI insertion will be performed using single-stage surgery. Patients in the control group already underwent BAHI insertion using two-stage surgery.

Recruitment and consent:

All children planned for implantation with bone-anchored hearing implants will be screened for inclusion in the present study. Patients who meet the inclusion criteria will be approached for participation by their ENT-specialist, after patients' and parents/caretakers' approval they will be informed and screened for participation by one of the researchers. The study protocol will be discussed with the potential study participant and his/her parents/caretakers by the researcher. The potential study participant and his/her parents/caretakers will be given/sent the Informed Consent Form to read. Potential study participants will be encouraged to discuss the study with family members and personal physician(s) before deciding whether to participate in the study. Patients and their parents/caretakers have 14 days to consider their decision. In order to participate in the study, both parents/caretakers need to sign the informed consent form.

Data handling:

Data captured will be recorded in Castor using electronic Case Report Forms (eCRFs). All data, patient and product related, must be accurately recorded in the eCRF by the delegated site staff. All users of the Castor system have personal, password protected accounts allowing tracking of all data entry in the system. Data management and data cleaning will be performed in the eCRF using the queries function to ensure traceability of all data entry and changes by the assigned data manager. Data including patient identifying information (i.e. name, initials, birth date) will be stored on a secured network drive using a code. Only the investigator who has the code can correlate the data with the patient's name and date of birth. It is the responsibility of the investigator to make sure that patient identification listings with patient code and identity are kept. Raw measurement data and other data such as historical information will be storedin the patient file, since data may be partly acquired and/or evaluated during standard patient care to limit the amount of extra procedures and hospital visits. For data analyses, data will be exported and stored in a digital research environment, separate from the key to the code. After completion of the study data collection and final monitoring visit, the electronic database will be locked and exported to SPSS format, which will be archived for 15 years after completion of the study. The coded study data will be archived separately from the key to the subject code in a secured digital research environment, also for a period of 15 years.

Reporting (severe) adverse events:

The investigator will report the Severe Adverse Events (SAEs) through the web portal ToetsingOnline to the accredited Medical Ethical Committee (METC) that approved the protocol, within 7 days of first knowledge for SAEs that result in death or are life threatening followed by a period of maximum of 8 days to complete the initial preliminary report. All other SAEs will be reported within a period of maximum 15 days after the investigator has first knowledge of the serious adverse events.

Device deficiency:

Inadequacy of an investigational medical device related to its identity, quality, durability, reliability, safety or performance. This may include malfunctions, use error, or inadequacy in the information supplied by the manufacturer. Device deficiency's will be logged together with an assessment by the investigator and reported to the manufacturer where applicable.

Follow-up of adverse events:

All Adverse Events (AEs) will be followed until they have abated, or until a stable situation has been reached. Depending on the event, follow up may require additional tests or medical procedures as indicated, and/or referral to the general physician or a medical specialist. SAEs need to be reported until the end of study within the Netherlands, as defined in the protocol.

Monitoring and Quality Assurance:

In accordance with the guidelines of the 'Dutch Federation of university medical centers' (NFU) for monitoring of studies with negligible risk, a qualified monitor of another department of the Radboudumc, who is not part of the research team of this study, will be appointed. 28% of informed consents, 10% of inclusion and exclusion criteria (and three subjects who were enrolled first), 10% source data verification, reported SAEs and 10% of participants with regard to missed SAEs will be monitored.

Statistical analysis:

The main analyses will be the comparison between the test group, in which single-stage surgery is performed and the control group undergoing two-stage surgery.

Concerning the primary outcome, the proportions of implant loss in the test and control group will be compared using an exact binominal test and a one tailed confidence interval of 95%.

Secondary outcome measures will be compared between groups using the unpaired t-test (normally distributed data or Mann-Whitney U tests (not normally distributed data) for continuous variables, Mantel Haenszel chi-square test for ordered categorical variables, Fisher's exact test for dichotomous variables and Chi-square test for non-ordered categorical variables. If significant differences are found for baseline variables between the test group and the control group a complementary analysis between the two groups will be performed with adjustment for these variables.

Handling of missing data for secondary and tertiary endpoints (especially applicable for control group data), depends on the reason why this data is missing and on the amount of missing data. Therefore decisions on handling of missing data will be made after all data is collected.

All tests will be performed using a confidence interval of 95% and a significance level of 0.05

Study Design


Hearing Impairment, Conductive


Single-stage surgery, Two-stage surgery


Not yet recruiting


Radboud University

Results (where available)

View Results


Published on BioPortfolio: 2019-08-05T15:53:31-0400

Clinical Trials [13293 Associated Clinical Trials listed on BioPortfolio]

Single-stage Surgery Using the BI300 Implant

Over the last few decades, the classical two-stage surgical procedure for inserting bone-anchored hearing implants (BAHIs) has been modified in adults into a single-stage procedure. This a...

Use of ADHEAR, a Non-Implantable Bone Conduction Hearing System, in Children With Single Sided Deafness and/or Conductive Hearing Loss

A hearing loss affects the quality of life and the natural development of children. The new generation of hearing devices provides a huge number of options to them. These new hearing aids...

Evaluation of the BHX Implant in Children With a BAHS

The purpose of this study is to in a proactive manner collect high quality data from pediatric patients who have undergone a bone anchored hearing surgery, using the Ponto BHX implant, in ...

Ambispective Clinical Evaluation of Sophono™

Study to accumulate post-market clinical evidence for the safety and effectiveness of the Sophono Alpha 2 and Alpha 2 MPO systems in subjects diagnosed with conductive hearing loss, single...

Clinical Trial on Alzheimer Disease, Presbycusis and Hearing Aids

This is a 12-months’ randomized clinical trial that aims at studying the benefit of bilateral hearing aids in hearing impaired patients suffering from a slight to moderate stage Alzheime...

PubMed Articles [24835 Associated PubMed Articles listed on BioPortfolio]

Combining correction of pectus excavatum and open heart surgery in a single-stage procedure.

The presence of pectus excavatum (PE) in patients undergoing open heart surgery is rare and no consensus has been reached regarding the surgical approach. Thus, in this paper we present in details a s...

LESS with Suture Suspension for Early-Stage Adnexa Cancer Staging.

Laparoendoscopic single-site surgery has been used in treating gynecologic diseases including early-stage cervical and endometrial cancer, but less so in early-stage adnexal cancer. We aimed to demons...

Safety and efficacy of transcutaneous bone conduction implant surgery for hearing improvement in microtia patients with bilateral hearing impairment.

In microtia patients with bilateral hearing impairment, hearing improvement is crucial for language development and performance. External auditory canal reconstruction (EACR) has been performed to imp...

Disparities in surgery for early-stage cancer: the impact of refusal.

For early-stage cancer surgery is often curative, yet refusal of recommended surgical interventions may be contributing to disparities in patient treatment. This study aims to assess predictors of ear...

Outcomes of surgery versus chemoradiotherapy in patients with clinical or pathologic stage N3 non-small cell lung cancer.

Because surgery is rarely recommended, there is minimal literature comparing the outcomes of surgery and chemoradiation in stage N3 non-small cell lung cancer (NSCLC). We examined the outcomes of defi...

Medical and Biotech [MESH] Definitions

Hearing loss due to damage or impairment of both the conductive elements (HEARING LOSS, CONDUCTIVE) and the sensorineural elements (HEARING LOSS, SENSORINEURAL) of the ear.

The stage in the first meiotic prophase, following ZYGOTENE STAGE, when CROSSING OVER between homologous CHROMOSOMES begins.

The process of TOOTH formation. It is divided into several stages including: the dental lamina stage, the bud stage, the cap stage, and the bell stage. Odontogenesis includes the production of tooth enamel (AMELOGENESIS), dentin (DENTINOGENESIS), and dental cementum (CEMENTOGENESIS).

Professionals skilled at diagnostic testing of hearing, HEARING IMPAIRMENT, and CORRECTION OF HEARING IMPAIRMENT by non-medical or non-surgical means.

A rare PARAGANGLIOMA involving the GLOMUS TYMPANICUM, a collection of chemoreceptor tissue adjacent to the TYMPANIC CAVITY. It can cause TINNITUS and conductive hearing loss (HEARING LOSS, CONDUCTIVE).

More From BioPortfolio on "Single-stage Surgery Using the BHX Implant"

Quick Search

Relevant Topics

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...

Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Hearing, auditory perception, or audition is the ability to perceive sound by detecting vibrations, changes in the pressure of the surrounding medium through time, through an organ such as the ear. Sound may be heard through solid, liquid, or gaseous mat...

Searches Linking to this Trial